BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$8.98
+1.58%
Mkt Cap $1.80B
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (12 analysts)
$14.40
Range $8.00 – $25.00
Implied Upside
+60.4%
Consensus $14.40 vs current $8.98
NASDAQ·Healthcare·Biotechnology
$8.98
+1.58%
Mkt Cap $1.80B
Buy
3
Hold
1
Sell
0
Price Target (12 analysts)
$14.40
Range $8.00 – $25.00
+60.4%
Consensus $14.40 vs current $8.98